CD20 monoclonal antibodies
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. The complex can be recognized and destroyed by phagocytes or used for other diagnostic purposes.
Natural antibodies are proteins made by the B-lymphocytes in response to antigens. Each B-cell makes only one type of antibody. For therapeutic purposes a significant amount of a particular antibody is needed. These are obtained from a culture that gives a one type of antibody, which are called monoclonal antibodies.
CD20 monoclonal antibodies are targeted against B-cell antigens, and are used in the treatment of B-cell Non-Hodgkin
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
|
|---|---|---|---|
| Arzerra (Pro, More...) generic name: ofatumumab |
0 reviews | 9.0 | |
| Rituxan (Pro, More...) generic name: rituximab |
13 reviews | 8.7 | |
| Bexxar (Pro, More...) generic name: iodine i 131 tositumomab |
0 reviews | 0.0 | |
| Bexxar Dosimetric (More...) generic name: tositumomab |
0 reviews | 0.0 | |
| BexxarTherapeutic (More...) generic name: tositumomab |
0 reviews | 0.0 | |
| In-111 Zevalin (More...) generic name: ibritumomab |
0 reviews | 0.0 | |
| Y-90 Zevalin (More...) generic name: ibritumomab |
0 reviews | 0.0 | |
| Zevalin (Pro, More...) generic name: ibritumomab |
0 reviews | 0.0 | |
See also
Medical conditions associated with CD20 monoclonal antibodies:
